Legal & General Group PLC Clearside Biomedical, Inc. Transaction History

Legal & General Group PLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 13, 2019	SELL	$0.59 - $1.32 $2,456 - $5,496	-4,164 Closed	0 $0
Q2 2018 Aug 10, 2018	BUY	$8.91 - $14.54 $3,831 - $6,252	430 Added 11.52%	4,164 $45,000
Q1 2018 May 17, 2018	BUY	$5.57 - $14.28 $3,854 - $9,881	692 Added 22.75%	3,734 $40,000
Q4 2017 Feb 13, 2018	BUY	$5.78 - $9.12 $17,582 - $27,743	3,042	3,042 $21,000

12.2M

54.7K

50.7K

Ticker CLSD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 60,190,700
Market Cap $60.8M
Description
Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. The company offers XIPERE, a triamcinolone acetonide suprachoroidal injectable suspension for the treatment of uveitis macular edema. It also develops CLS-AX, an axitinib injec...

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

Stay updated on Legal & General Group PLC with notifications on news.